Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics Inc.
WKN: A3DMHJ / Symbol: AVTX / Name: Avalo Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,041 €
2,50 %
Avalo Therapeutics (AVTX) had its price target lowered by HC Wainwright from $40.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (AVTX) had its price target lowered by Wedbush from $40.00 to $34.00. They now have an "outperform" rating on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (AVTX) is now covered by Bank of America Corporation. They set a "buy" rating and a $35.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (AVTX) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (AVTX) is now covered by Leerink Partners. They set an "outperform" rating and a $38.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (AVTX) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
Ratings data for AVTX provided by MarketBeat
Neueste Beiträge
StockNews_com in Atkore International Group Inc diskutieren